IMVT- Immunovant, Inc.

Name: Immunovant, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Immunovant, Inc. (IMVT) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. IMVT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Venker Eric	1.48M	$42.69M	-
Other	Geffner Michael	218.0K	$6.31M	-
Other	Stout Jay S	199.7K	$5.78M	-
COO	Gloria Melanie	175.9K	$5.09M	-
Other	Van Tuyl Christopher	152.2K	$4.41M	-

Activity

Buys and sells only

Transactions

10 filings · page 4

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 15, 2025	Salzmann Peter51	Chief Executive Officer	Sell	8,767	$23.83	$208,899.97	-0.5%	-36.6%	+6.6%
Jan 8, 2025	Barnett Eva Renee58	Chief Financial Officer	Sell	4,105	$24.10	$98,930.50	-1.2%	-43.7%	+11.3%
Jan 8, 2025	Salzmann Peter51	Chief Executive Officer	Sell	5,105	$24.10	$123,030.50	-0.5%	-43.7%	+11.3%
Dec 2, 2024	Hughes Douglas J.	Director	Sell	5,425	$28.54	$154,829.50	-4.3%	-35.9%	-23.5%
Dec 2, 2024	Pande Atul74	Director	Sell	7,750	$28.54	$221,185.00	-8.2%	-35.9%	-23.5%
Nov 20, 2024	Levine Mark S.66	Chief Legal Officer	Sell	3,650	$25.45	$92,892.50	-1.1%	-20.4%	-12.9%
Nov 20, 2024	MacIas William L.51	Chief Medical Officer	Sell	3,353	$25.45	$85,333.85	-0.9%	-20.4%	-12.9%
Nov 20, 2024	Barnett Eva Renee58	Chief Financial Officer	Sell	4,174	$25.45	$106,228.30	-1.2%	-20.4%	-12.9%
Nov 20, 2024	Salzmann Peter51	Chief Executive Officer	Sell	16,692	$25.45	$424,811.40	-1.7%	-20.4%	-12.9%
Oct 23, 2024	Levine Mark S.66	Chief Legal Officer	Sell	4,361	$29.53	$128,780.33	-1.3%	-21.4%	-37.6%

← PrevPage 4Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC